Skip to main content
. Author manuscript; available in PMC: 2012 Aug 23.
Published in final edited form as: Semin Immunopathol. 2011 Apr 28;33(4):321–334. doi: 10.1007/s00281-011-0270-z

Fig. 2.

Fig. 2

Frequency of classical HLA class I antigen downregulation and HLA class II antigen expression in malignant lesions of different embryological origin. Solid tumors for which more than 50 primary lesions have been analyzed for a classical and b HLA class II expression are shown. BCC cutaneous basal cell carcinoma, ESO esophageal carcinoma, HNSCC head and neck squamous cell carcinoma, MM malignant melanoma, OV ovarian carcinoma, RCC renal cell carcinoma, SCC squamous cell carcinoma, UM uveal melanoma